Log in

CVE:FIRESupreme Cannabis Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume5.24 million shs
Average Volume1.17 million shs
Market CapitalizationC$655.28 million
P/E RatioN/A
Dividend YieldN/A
The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.
Read More
Supreme Cannabis logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesC$12.43 million
Book ValueC$0.57 per share



Market CapC$655.28 million
Next Earnings DateN/A
OptionableNot Optionable

Receive FIRE News and Ratings via Email

Sign-up to receive the latest news and ratings for FIRE and its competitors with MarketBeat's FREE daily newsletter.

Supreme Cannabis (CVE:FIRE) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Supreme Cannabis?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Supreme Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Supreme Cannabis.

What price target have analysts set for FIRE?

2 equities research analysts have issued 12 month target prices for Supreme Cannabis' shares. Their forecasts range from C$0.35 to C$0.90. On average, they anticipate Supreme Cannabis' stock price to reach C$0.63 in the next year. View analysts' price targets for Supreme Cannabis.

Has Supreme Cannabis been receiving favorable news coverage?

Media coverage about FIRE stock has trended somewhat positive on Saturday, according to InfoTrie. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Supreme Cannabis earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutSupreme Cannabis.

Who are some of Supreme Cannabis' key competitors?

What other stocks do shareholders of Supreme Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Supreme Cannabis investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), 1933 Industries (TGIF), Green Organic Dutchman (TGOD), Advanced Micro Devices (AMD), Aphria (APHA), Hydropothecary (THCX) and MedReleaf (LEAF).

Who are Supreme Cannabis' key executives?

Supreme Cannabis' management team includes the following people:
  • Mr. Navdeep Dhaliwal, CEO & Director
  • Mr. John Alexander Fowler, Pres, Founder & Director
  • Mr. Dimitre Naoumov, Chief Financial Officer
  • Mr. Sunpreet Gokhale, Gen. Counsel
  • Mr. Scott Robertson Walters, VP of Corp. Devel. & Director

What is Supreme Cannabis' stock symbol?

Supreme Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "FIRE."

How big of a company is Supreme Cannabis?

Supreme Cannabis has a market capitalization of C$0.00 and generates C$12.43 million in revenue each year.

What is Supreme Cannabis' official website?

The official website for Supreme Cannabis is www.supreme.ca.

How can I contact Supreme Cannabis?

Supreme Cannabis' mailing address is 371 Jones Ave, TORONTO, ON M4J 3G5, Canada. The company can be reached via phone at +1-416-6307272.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.